Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 7, 2013; 19(45): 8321-8325
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8321
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8321
Gastrojejunostomy in patients with unresectable pancreatic head cancer - the use of Roux loop significantly shortens the hospital length of stay
Dariusz Szymanski, Adam Durczynski, Michal Nowicki, Janusz Strzelczyk, Department of General and Transplant Surgery, Barlicki University Hospital, Medical University of Lodz, 0-153 Lodz, Poland
Author contributions: All authors contributed equally to this work.
Correspondence to: Adam Durczynski MD, PhD, Department of General and Transplant Surgery, Medical University of Lodz, Barlicki University Hospital, Kopcinskiego Street 22, 90-153 Lodz, Poland. a.durczynski@interia.pl
Telephone: +48-42-6776755 Fax: +48-42-6791091
Received: May 7, 2013
Revised: August 12, 2013
Accepted: September 15, 2013
Published online: December 7, 2013
Revised: August 12, 2013
Accepted: September 15, 2013
Published online: December 7, 2013
Core Tip
Core tip: The lower rate of delayed gastric emptying, which determines lower use of prokinetics after Roux compared to conventional antegastric gastroenterostomy (GE) suggested that prophylactic Roux GE should be performed during surgical exploration of patients with unresectable pancreatic head tumors. The length of hospital stay is shorter following palliative Roux GE, thus the treatment costs of these patients are likely to be smaller. Further research is needed on the cost-effectiveness of prophylactic Roux GE in unresectable pancreatic cancer.